Acetylcholinesterase (AChE) plays an important role in the pathogenesis of
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …

Alzheimer's disease (AD) is a slowly progressive neurodegenerative disease
conceptualized as a continuous process, ranging from mild cognitive impairment (MCI), to …

Although women experience significantly higher tau burden and increased risk for
Alzheimer's disease (AD) than men, the underlying mechanism for this vulnerability has not …

This study investigated the inhibitory mechanism of quercetin in acetylcholinesterase
(AChE) and its neuroprotective effects on β-amyloid25–35-induced oxidative stress injury in …

Multitarget anti-Alzheimer agents are the focus of very intensive research. Through a
comprehensive bibliometric analysis of the publications in the period 1990–2020, we have …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that leads to
dementia and patient death. AD is characterized by intracellular neurofibrillary tangles …

Alzheimer's disease (AD) is multifactorial, progressive and the most predominant cause of
cognitive impairment and dementia worldwide. The current “one-drug, one-target” approach …

Alzheimer's disease (AD) is a neurodegenerative disorder which is characterized by β-
amyloid (Aβ) aggregation, τ-hyperphosphorylation, and loss of cholinergic neurons. The …

Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
progressive memory loss, declining language skills and other cognitive disorders. AD has …

Ginkgo biloba (GB) extracts have been used in clinical studies as an alternative therapy for
Alzheimer's disease (AD), but the exact bioaction mechanism has not yet been elucidated. In …